Glenmark Pharma launches anti-diabetes drug in India
Glenmark Pharma, a Drug major, has launched novel drug Remogliflozin in India, which will be beneficial to treat type-2 diabetes […]
Glenmark Pharma, a Drug major, has launched novel drug Remogliflozin in India, which will be beneficial to treat type-2 diabetes […]